<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">22040910</PMID>
      <DateCompleted>
        <Year>2012</Year>
        <Month>06</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-3634</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Seminars in cell &amp; developmental biology</Title>
          <ISOAbbreviation>Semin Cell Dev Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Eph/ephrin signaling in epidermal differentiation and disease.</ArticleTitle>
        <Pagination>
          <StartPage>92</StartPage>
          <EndPage>101</EndPage>
          <MedlinePgn>92-101</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semcdb.2011.10.017</ELocationID>
        <Abstract>
          <AbstractText>Eph receptor tyrosine kinases mediate cell-cell communication by interacting with ephrin ligands residing on adjacent cell surfaces. In doing so, these juxtamembrane signaling complexes provide important contextual information about the cellular microenvironment that helps orchestrate tissue morphogenesis and maintain homeostasis. Eph/ephrin signaling has been implicated in various aspects of mammalian skin physiology, with several members of this large family of receptor tyrosine kinases and their ligands present in the epidermis, hair follicles, sebaceous glands, and underlying dermis. This review focuses on the emerging role of Eph receptors and ephrins in epidermal keratinocytes where they can modulate proliferation, migration, differentiation, and death. The activation of Eph receptors by ephrins at sites of cell-cell contact also appears to play a key role in the maturation of intercellular junctional complexes as keratinocytes move out of the basal layer and differentiate in the suprabasal layers of this stratified, squamous epithelium. Furthermore, alterations in the epidermal Eph/ephrin axis have been associated with cutaneous malignancy, wound healing defects and inflammatory skin conditions. These collective observations suggest that the Eph/ephrin cell-cell communication pathway may be amenable to therapeutic intervention for the purpose of restoring epidermal tissue homeostasis and integrity in dermatological disorders.</AbstractText>
          <CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Samantha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Bingcheng</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Getsios</LastName>
            <ForeName>Spiro</ForeName>
            <Initials>S</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA155676</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>DK077876</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>CA92259</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA152371</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK077876</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA092259</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2011</Year>
          <Month>10</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Semin Cell Dev Biol</MedlineTA>
        <NlmUniqueID>9607332</NlmUniqueID>
        <ISSNLinking>1084-9521</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036081">Receptors, Eph Family</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002448" MajorTopicYN="N">Cell Adhesion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002454" MajorTopicYN="Y">Cell Differentiation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004817" MajorTopicYN="N">Epidermis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015603" MajorTopicYN="N">Keratinocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036081" MajorTopicYN="N">Receptors, Eph Family</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2011</Year>
          <Month>7</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2011</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2011</Year>
          <Month>11</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2011</Year>
          <Month>11</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2012</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22040910</ArticleId>
        <ArticleId IdType="mid">NIHMS341175</ArticleId>
        <ArticleId IdType="pmc">PMC3378995</ArticleId>
        <ArticleId IdType="doi">10.1016/j.semcdb.2011.10.017</ArticleId>
        <ArticleId IdType="pii">S1084-9521(11)00205-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol. 2009;10(3):207–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2760218</ArticleId>
            <ArticleId IdType="pubmed">19209183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koster MI, Roop DR. Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol. 2007;23:93–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17489688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19043850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green KJ, Simpson CL. Desmosomes: new perspectives on a classic. J Invest Dermatol. 2007;127(11):2499–515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gumbiner BM. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 2005;6(8):622–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16025097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen PJ, Telegan B, Lavker RM, Wheelock MJ. E-cadherin and P-cadherin have partially redundant roles in human epidermal stratification. Cell Tissue Res. 1997;288(2):307–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9082966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 2007;127(11):2525–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tinkle CL, Pasolli HA, Stokes N, Fuchs E. New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad Sci USA. 2008;105(40):15405–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2547466</ArticleId>
            <ArticleId IdType="pubmed">18809908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tunggal JA, Helfrich I, Schmitz A, Schwarz H, Gunzel D, Fromm M, et al.  E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J. 2005;24(6):1146–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC556407</ArticleId>
            <ArticleId IdType="pubmed">15775979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wheelock MJ, Jensen PJ. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol. 1992;117(2):415–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2289421</ArticleId>
            <ArticleId IdType="pubmed">1373144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panelos J, Massi D. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol Ther. 2009;8(21):1986–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19783903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watt FM, Estrach S, Ambler CA. Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol. 2008;20(2):171–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2324124</ArticleId>
            <ArticleId IdType="pubmed">18342499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 2001;20(13):3427–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125257</ArticleId>
            <ArticleId IdType="pubmed">11432830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genander M, Holmberg J, Frisen J. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells. 2010;28(7):1196–205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20506314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC, et al.  Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res. 2006;66(14):7050–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16849550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin S, Gordon K, Kaplan N, Getsios S. Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1. Mol Biol Cell. 2010;21(22):3902–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2982116</ArticleId>
            <ArticleId IdType="pubmed">20861311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh R, Blumenberg M. Specific and shared targets of ephrin A signaling in epidermal keratinocytes. J Biol Chem. 2011;286(11):9419–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3059010</ArticleId>
            <ArticleId IdType="pubmed">21193391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egawa G, Osawa M, Uemura A, Miyachi Y, Nishikawa S. Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol. 2009;129(10):2386–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19571816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moss A, Alvares D, Meredith-Middleton J, Robinson M, Slater R, Hunt SP, et al.  Ephrin-A4 inhibits sensory neurite outgrowth and is regulated by neonatal skin wounding. Eur J Neurosci. 2005;22(10):2413–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16307584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munthe E, Finne EF, Aasheim HC. Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells. BMC Immunol. 2004;5:9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC443508</ArticleId>
            <ArticleId IdType="pubmed">15176971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H. Epha2 is a critical oncogene in melanoma. Oncogene. 2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3175290</ArticleId>
            <ArticleId IdType="pubmed">21666714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vihanto MM, Plock J, Erni D, Frey BM, Frey FJ, Huynh-Do U. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J. 2005;19(12):1689–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16081502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang G, Zhang G, Pittelkow MR, Ramoni M, Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol. 2006;126(11):2490–506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16888633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lackmann M, Boyd AW. Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal. 2008;1(15):re2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18413883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer. 2010;10(3):165–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2921274</ArticleId>
            <ArticleId IdType="pubmed">20179713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005;6(6):462–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15928710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, et al.  Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 1996;17(1):9–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8755474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, et al.  Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci. 2004;7(5):501–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15107857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph–ephrin promiscuity is now crystal clear. Nat Neurosci. 2004;7(5):417–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15114347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiramoto-Yamaki N, Takeuchi S, Ueda S, Harada K, Fujimoto S, Negishi M, et al.  Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J Cell Biol. 2010;190(3):461–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2922637</ArticleId>
            <ArticleId IdType="pubmed">20679435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, et al.  EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell. 2009;16(1):9–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2860958</ArticleId>
            <ArticleId IdType="pubmed">19573808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noren NK, Yang NY, Silldorff M, Mutyala R, Pasquale EB. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. Biochem J. 2009;422(3):433–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2866036</ArticleId>
            <ArticleId IdType="pubmed">19552627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, et al.  Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol. 2009;174(4):1492–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2671379</ArticleId>
            <ArticleId IdType="pubmed">19264906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truitt L, Freywald T, DeCoteau J, Sharfe N, Freywald A. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. Cancer Res. 2010;70(3):1141–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20086179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kullander K, Mather NK, Diella F, Dottori M, Boyd AW, Klein R. Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo. Neuron. 2001;29(1):73–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11182082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, et al.  Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer. 1999;84(5):494–501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10502726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao H, Wang B. Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol. 2009;41(4):762–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3108796</ArticleId>
            <ArticleId IdType="pubmed">18761422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale EB. Eph–ephrin bidirectional signaling in physiology and disease. Cell. 2008;133(1):38–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18394988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pitulescu ME, Adams RH. Eph/ephrin molecules—a hub for signaling and endocytosis. Genes Dev. 2010;24(22):2480–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2975924</ArticleId>
            <ArticleId IdType="pubmed">21078817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herath NI, Boyd AW. The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer. 2010;126(9):2003–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20039322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kojima T, Chung TY, Chang JH, Sayegh R, Casanova FH, Azar DT. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB–ephrinB in vascularized corneas. Cornea. 2007;26(5):569–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17525654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merlos-Suarez A, Batlle E. Eph–ephrin signalling in adult tissues and cancer. Curr Opin Cell Biol. 2008;20(2):194–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18353626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hafner C, Becker B, Landthaler M, Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol. 2006;19(10):1369–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16862074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alford SC, Bazowski J, Lorimer H, Elowe S, Howard PL. Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers. Exp Cell Res. 2007;313(20):4170–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17707797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T. A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood. 2000;95(1):221–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10607706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science. 2000;289(5483):1360–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10958785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuchs E. Scratching the surface of skin development. Nature. 2007;445(7130):834–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2405926</ArticleId>
            <ArticleId IdType="pubmed">17314969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavker RM, Sun TT, Oshima H, Barrandon Y, Akiyama M, Ferraris C, et al.  Hair follicle stem cells. J Investig Dermatol Symp Proc. 2003;8(1):28–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12894992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, et al.  Defining the epithelial stem cell niche in skin. Science. 2004;303(5656):359–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2405920</ArticleId>
            <ArticleId IdType="pubmed">14671312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Midorikawa T, Chikazawa T, Yoshino T, Takada K, Arase S. Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis. J Dermatol Sci. 2004;36(1):25–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15488702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coulthard MG, Lickliter JD, Subanesan N, Chen K, Webb GC, Lowry AJ, et al.  Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues. Growth Factors. 2001;18(4):303–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11519828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada Y, Midorikawa T, Oura H, Yoshino T, Ohdera M, Kubo Y, et al.  Ephrin-A3 not only increases the density of hair follicles but also accelerates anagen development in neonatal mice. J Dermatol Sci. 2008;52(3):178–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18640011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin H, Noberini R, Huan X, Shi J, Pasquale EB, Song J. Structural characterization of the EphA4–Ephrin-B2 complex reveals new features enabling Eph–ephrin binding promiscuity. J Biol Chem. 2004;285(1):644–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2804212</ArticleId>
            <ArticleId IdType="pubmed">19875447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singla N, Goldgur Y, Xu K, Paavilainen S, Nikolov DB, Himanen JP. Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations. Biochem Biophys Res Commun. 2010;399(4):555–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2949057</ArticleId>
            <ArticleId IdType="pubmed">20678482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao H, Nickel CH, Cantley LG, Bruggeman LA, Bennardo LN, Wang B. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J Cell Biol. 2003;162(7):1281–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2173949</ArticleId>
            <ArticleId IdType="pubmed">14517207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, et al.  Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol. 2001;3(5):527–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11331884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen AB, Stockhausen MT, Poulsen HS. Cell adhesion and EGFR activation regulate EphA2 expression in cancer. Cell Signal. 2010;22(4):636–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19948216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C, et al.  A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell. 2005;8(2):111–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16098464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simpson CL, Kojima S, Getsios S. RNA interference in keratinocytes and an organotypic model of human epidermis. Methods Mol Biol. 2010;585:127–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19908001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell TN, Davy A, Liu Y, Arcellana-Panlilio M, Robbins SM. Distinct membrane compartmentalization and signaling of ephrin-A5 and ephrin-B1. Biochem Biophys Res Commun. 2008;375(3):362–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18694724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gauthier LR, Robbins SM. Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them? Life Sci. 2003;74(2–3):207–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14607248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kao TJ, Kania A. Ephrin-mediated cis-attenuation of Eph receptor signaling is essential for spinal motor axon guidance. Neuron. 2011;71(1):76–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21745639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, et al.  Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell. 2005;121(1):127–39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15820684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dudanova I, Klein R. The axon's balancing act: cis- and trans-interactions between Ephs and ephrins. Neuron. 2011;71(1):1–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21745632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell–cell contacts. Mol Biol Cell. 2009;20(7):1949–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2663931</ArticleId>
            <ArticleId IdType="pubmed">19193766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orsulic S, Kemler R. Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci. 2000;113(Pt 10):1793–802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10769210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J Biol Chem. 2005;280(51):42375–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16236711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, Kinch MS. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ. 1999;10(9):629–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10511313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang WB, Brantley-Sieders DM, Parker MA, Reith AD, Chen J. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis. Oncogene. 2005;24(53):7859–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16103880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jorgensen C, Sherman A, Chen GI, Pasculescu A, Poliakov A, Hsiung M, et al.  Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science. 2009;326(5959):1502–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20007894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker-Daniels J, Riese DJ, 2nd, Kinch MS. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res. 2002;1(1):79–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12496371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang G, Hunter S, Hwang Y, Chen J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-kinase-dependent Rac1 activation. J Biol Chem. 2007;282(4):2683–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17135240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Ligation of EphA2 by ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun. 2004;320(4):1096–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15249202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wykosky J, Palma E, Gibo DM, Ringler S, Turner CP, Debinski W. Soluble monomeric ephrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene. 2008;27(58):7260–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3683835</ArticleId>
            <ArticleId IdType="pubmed">18794797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen AB, Pedersen MW, Stockhausen MT, Grandal MV, van Deurs B, Poulsen HS. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. Mol Cancer Res. 2007;5(3):283–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17374733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoo S, Kim Y, Noh H, Lee H, Park E, Park S. Endocytosis of EphA receptors is essential for the proper development of the retinocollicular topographic map. EMBO J. 2011;30(8):1593–607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3102278</ArticleId>
            <ArticleId IdType="pubmed">21343910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasen K, Cerretti DP, Huynh-Do U. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway. Traffic. 2008;9(2):251–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18034775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Lee H, Kim Y, Yoo S, Park E, Park S. The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors. Mol Cell Biol. 2010;30(7):1582–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2838079</ArticleId>
            <ArticleId IdType="pubmed">20100865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharfe N, Freywald A, Toro A, Roifman CM. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol. 2003;170(12):6024–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12794130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Ota S, Kataoka H, Kanamori M, Li Z, Band H, et al.  Negative regulation of EphA2 receptor by Cbl. Biochem Biophys Res Commun. 2002;296(1):214–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12147253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leone M, Cellitti J, Pellecchia M. NMR studies of a heterotypic Sam–Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor. Biochemistry. 2008;47(48):12721–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2674315</ArticleId>
            <ArticleId IdType="pubmed">18991394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nievergall E, Janes PW, Stegmayer C, Vail ME, Haj FG, Teng SW, et al.  PTP1B regulates Eph receptor function and trafficking. J Cell Biol. 2011;191(6):1189–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3002030</ArticleId>
            <ArticleId IdType="pubmed">21135139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, et al.  EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem. 2005;280(40):34008–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16051609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, Hua R, Xiao W, Burdon KP, Bhattacharya SS, Craig JE, et al.  Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract. Hum Mutat. 2009;30(5):E603–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19306328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, et al.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell. 2005;123(2):291–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16239146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janes PW, Wimmer-Kleikamp SH, Frangakis AS, Treble K, Griesshaber B, Sabet O, et al.  Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10. PLoS Biol. 2009;7(10):e1000215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2753297</ArticleId>
            <ArticleId IdType="pubmed">19823572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salaita K, Nair PM, Petit RS, Neve RM, Das D, Gray JW, et al.  Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science. 2010;327(5971):1380–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895569</ArticleId>
            <ArticleId IdType="pubmed">20223987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber S, Niessen MT, Prox J, Lullmann-Rauch R, Schmitz A, Schwanbeck R, et al.  The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development. 2011;138(3):495–505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3014635</ArticleId>
            <ArticleId IdType="pubmed">21205794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Goldgur Y, Miao H, Myshkin E, Guo H, Buck M, et al.  Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep. 2009;10(7):722–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2727437</ArticleId>
            <ArticleId IdType="pubmed">19525919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himanen JP, Yermekbayeva L, Janes PW, Walker JR, Xu K, Atapattu L, et al.  Architecture of Eph receptor clusters. Proc Natl Acad Sci USA. 2010;107(24):10860–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2890748</ArticleId>
            <ArticleId IdType="pubmed">20505120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seiradake E, Harlos K, Sutton G, Aricescu AR, Jones EY. An extracellular steric seeding mechanism for Eph–ephrin signaling platform assembly. Nat Struct Mol Biol. 2010;17(4):398–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3672960</ArticleId>
            <ArticleId IdType="pubmed">20228801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michels C, Aghdam SY, Niessen CM. Cadherin-mediated regulation of tight junctions in stratifying epithelia. Ann N Y Acad Sci. 2009;1165:163–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19538302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL, et al.  Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol. 2009;185(7):1243–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2712955</ArticleId>
            <ArticleId IdType="pubmed">19546243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, Greer PL, et al.  Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron. 2005;46(2):205–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15848800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang WB, Brantley-Sieders DM, Hwang Y, Ham AJ, Chen J. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase. J Biol Chem. 2008;283(23):16017–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2414276</ArticleId>
            <ArticleId IdType="pubmed">18387945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murai KK, Pasquale EB. New exchanges in Eph-dependent growth cone dynamics. Neuron. 2005;46(2):161–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15848793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noren NK, Pasquale EB. Eph receptor–ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal. 2004;16(6):655–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15093606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosas OR, Figueroa JD, Torrado AI, Rivera M, Santiago JM, Konig-Toro F, et al.  Expression and activation of ephexin is altered after spinal cord injury. Dev Neurobiol. 2011;71(7):595–607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3514508</ArticleId>
            <ArticleId IdType="pubmed">20949525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmucker D, Zipursky SL. Signaling downstream of Eph receptors and ephrin ligands. Cell. 2001;105(6):701–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11440711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, et al.  EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell. 2001;105(2):233–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11336673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wimmer-Kleikamp SH, Nievergall E, Gegenbauer K, Adikari S, Mansour M, Yeadon T, et al.  Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells. Blood. 2008;112(3):721–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18385452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang WB, Ireton RC, Zhuang G, Takahashi T, Reynolds A, Chen J. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci. 2008;121(Pt 3):358–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18198190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med. 2009;206(13):2937–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2806471</ArticleId>
            <ArticleId IdType="pubmed">19995951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al.  Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(3):773–86. e1–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3049863</ArticleId>
            <ArticleId IdType="pubmed">21163515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bocharov EV, Mayzel ML, Volynsky PE, Goncharuk MV, Ermolyuk YS, Schulga AA, et al.  Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem. 2008;283(43):29385–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2662025</ArticleId>
            <ArticleId IdType="pubmed">18728013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bocharov EV, Mayzel ML, Volynsky PE, Mineev KS, Tkach EN, Ermolyuk YS, et al.  Left-handed dimer of EphA2 transmembrane domain: helix packing diversity among receptor tyrosine kinases. Biophys J. 2010;98(5):881–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830432</ArticleId>
            <ArticleId IdType="pubmed">20197042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behne MJ, Barry NP, Hanson KM, Aronchik I, Clegg RW, Gratton E, et al.  Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol. 2003;120(6):998–1006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12787127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang G, Njauw CN, Park JM, Naruse C, Asano M, Tsao H. EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res. 2008;68(6):1691–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4469360</ArticleId>
            <ArticleId IdType="pubmed">18339848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calautti E, Li J, Saoncella S, Brissette JL, Goetinck PF. Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem. 2005;280(38):32856–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16036919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrash BR, Menges CW, Pierce RH, McCance DJ. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem. 2006;281(17):12155–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16517604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plonka PM, Passeron T, Brenner M, Tobin DJ, Shibahara S, Thomas A, et al.  What are melanocytes really doing all day long? Exp Dermatol. 2009;18(9):799–819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2792575</ArticleId>
            <ArticleId IdType="pubmed">19659579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen LX, He YJ, Zhao SZ, Wu JG, Wang JT, Zhu LM, et al.  Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biol Ther. 2011;11(2):229–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21084858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eskandarpour M, Huang F, Reeves KA, Clark E, Hansson J. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer. 2009;124(1):16–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18814281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene. 2003;22(20):3070–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12789282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci. 2003;995:151–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12814947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther. 2006;5(2):228–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16481735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Margaryan NV, Strizzi L, Abbott DE, Seftor EA, Rao MS, Hendrix MJ, et al.  EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther. 2009;8(3):279–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3491659</ArticleId>
            <ArticleId IdType="pubmed">19223760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res. 2009;69(5):2072–81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19244130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-Ras during mouse skin carcinogenesis. Nature. 1986;322(6074):78–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3014349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamazaki T, Masuda J, Omori T, Usui R, Akiyama H, Maru Y. EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility. J Cell Sci. 2009;122(Pt 2):243–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19118217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis—part I: clinical and pathologic concepts. J Allergy Clin Immunol. 2011;127(5):1110–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21388665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulski JK, Kenworthy W, Bellgard M, Taplin R, Okamoto K, Oka A, et al.  Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med (Berl) 2005;83(12):964–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16283139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piruzian E, Bruskin S, Ishkin A, Abdeev R, Moshkovskii S, Melnik S, et al.  Integrated network analysis of transcriptomic and proteomic data in psoriasis. BMC Syst Biol. 2010;4(41)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2873316</ArticleId>
            <ArticleId IdType="pubmed">20377895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg IM, Goke M, Kanai M, Reinecker HC, Podolsky DK. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol. 1997;273(4 Pt 1):G824–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9357823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trautmann A, Altznauer F, Akdis M, Simon HU, Disch R, Brocker EB, et al.  The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol. 2001;117(4):927–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11676834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumortier A, Durham AD, Di Piazza M, Vauclair S, Koch U, Ferrand G, et al.  Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE. 2010;5(2):e9258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2823782</ArticleId>
            <ArticleId IdType="pubmed">20174635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol. 1995;104(6):895–901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7539469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanley JR. Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med. 1995;181(1):1–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2191837</ArticleId>
            <ArticleId IdType="pubmed">7806996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akiyama M. ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts. Hum Mutat. 2010;31(10):1090–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20672373</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
